InsiderGauge
Checking updates…
Dashboard

Patel Dinesh V Ph Dinsider trades

In SEC Form 4 filings, Patel Dinesh V Ph D is listed as President and CEO of Protagonist Therapeutics, Inc (PTGX). In the last 90 days, Patel Dinesh V Ph D sold $18.24M of Protagonist Therapeutics, Inc (PTGX) on the open market and bought none. All 3 sales were reported under a 10b5-1 trading plan.

Companies and roles

CompanyRoleTransactionsLast filed
PTGXProtagonist Therapeutics, IncPresident and CEO10Sep 10

Cluster buys

No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).

Form 4 historysince 2026-09-08

CompanyTradedFiledTypeSharesPriceValueOwned after10b5-1 planFiling
PTGXProtagonist Therapeutics, IncSep 10Sep 10M7,278$21.58$157,059530,246YesForm 4
PTGXProtagonist Therapeutics, IncSep 10Sep 10S7,278$144.10Sale −$1,048,760522,968YesForm 4
PTGXProtagonist Therapeutics, IncSep 10Sep 10M · derivative7,278$21.58$157,059not reportedYesForm 4
PTGXProtagonist Therapeutics, IncSep 9Sep 10M63,548$21.58$1,371,366586,516YesForm 4
PTGXProtagonist Therapeutics, IncSep 9Sep 10S63,548$146.18Sale −$9,289,447522,968YesForm 4
PTGXProtagonist Therapeutics, IncSep 9Sep 10M · derivative63,548$21.58$1,371,3667,278YesForm 4
PTGXProtagonist Therapeutics, IncSep 8Sep 10M54,174$21.58$1,169,075577,142YesForm 4
PTGXProtagonist Therapeutics, IncSep 8Sep 10S54,174$145.87Sale −$7,902,361522,968YesForm 4
PTGXProtagonist Therapeutics, IncSep 8Sep 10M · derivative54,174$21.58$1,169,07570,826YesForm 4
PTGXProtagonist Therapeutics, IncSep 3Sep 8G510$0.00$0522,968NoForm 4

Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.